ALFA Finder| Revenue growth | 33.7% Standalone growth; targeting 35% CAGR FY26-FY29. |
|---|---|
| Margins | FY26 EBITDA margin at 13.3% (Consolidated); 13.9% (Standalone). |
| Demand visibility | Strong for lead-free solutions and CPVC in India and MENA. |
| Management confidence | High; citing 'multi-pronged strategy' and 'global expansion'. |
Growth
FY26 Consolidated Revenue up 14.8% to ₹4,504.4mn; Standalone Revenue up 33.7% to ₹4,343.6mn. PAT up 3.7% YoY.
Outlook
Targeting >40% revenue growth in FY27 and 35% CAGR till FY29. Egypt facility operational by Q3FY27.
Risks
Global regulatory shifts and geopolitical risks impacting supply chains in new Egypt and Europe markets.
Earnings Call filed with NSE, NSE: PLATIND. Summary written with AI assistance from the document.
Platinum Industries Ltd: key numbers
- Share price
- ₹216.10
- Market cap
- ₹1,187 Cr
- Revenue (annual)
- ₹450.4 Cr
- Net profit (annual)
- ₹51.96 Cr
- P/E (TTM)
- 25.5×Sector 35.5×
- Promoter holding
- 70.03%+0.00% QoQ
- FII holding
- 0.18%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Platinum Industries Ltd
All →Platinum Industries Earnings Call Transcript: Key Takeaways
Q2 FY27 revenue rose 23.3% to ₹121.3 Cr, but EBITDA margin fell to 8.9% (from 13.8%) and PAT dropped to ₹7.6 Cr (from ₹11 Cr) on freight and Palghar ramp-up costs.
- Call
- Guides 35% growth
Platinum Industries Other Announcement
Platinum Industries filed a Crisil monitoring agency report on IPO proceeds for the quarter ended 30 September 2026. The report states no deviation from offer objects.
Platinum Industries Q2 FY27 Results: Net Profit ₹7.6 Cr, Down 30.9% YoY
Platinum Industries Ltd reported revenue from operations of ₹121.3 Cr (+23.3% YoY) and net profit of ₹7.6 Cr (-30.9% YoY) for Q2 FY27.
- Key figure
- Net profit ₹7.6 Cr · -30.9% YoY
Platinum Industries Board Meeting Date
Platinum Industries Ltd intimated a board meeting on November 4, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. Trading window closed from October 1, 2026.
Platinum Industries Other Announcement
Platinum Industries Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI regulations.
Platinum Industries Partnership
Platinum Industries' subsidiary, Rivadu Lifesciences, entered an exclusive sale/purchase agreement with Korea-based CAREGEN Co., Ltd. The partnership targets the Indian market for Caregen's functional food products.
- From
- CAREGEN Co., Ltd., Korea